Imaging Intravenous Iron
ConditionIron-deficiency
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Oxford
About this trial
The aim of this study is to track where the iron goes in different tissues in the hours, days and weeks after an intravenous iron infusion. We will track iron in tissues using MRI relaxometry parameters R1/R2/R2\* which are well established as accurate indicators of tissue iron content.
Eligibility criteria
Qualifiers
Participant is willing and able to give informed consent for participation in the study.
Aged 18 years or above.
Anaemia (haemoglobin less than 120g/L for women and less than 130g/L for men) and/or confirmed iron deficiency (ferritin less than 100mcg/L and/or transferrin saturation less than 20%).
Scheduled to receive intravenous iron for correction of iron deficiency.
Disqualifiers
Any MRI incompatible implants (e.g. cardiac, neuro, ocular implants, surgical clips, aneurysm clips, shrapnel/bullets)
Pregnant or lactating participant
Acute decompensated heart failure
Unstable clinical status
Trial design
Treatments tested in this trial
- Not listed
Trial groups
12 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov